Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells

Journal of Immunology

Volumn 165, Issue 9, 2000, Pages 5062-5068

  Iida, T ^a   Ohno, H ^a   Nakaseko, C ^a   Sakuma, M ^a   Takeda Ezaki, M ^a   Arase, H ^a   Kominami, E ^a   Fujisawa, T ^a   Saito, T ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CATHEPSIN D; CD4 ANTIGEN; CLATHRIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; ENDOCYTOSIS; LIGAND BINDING; LYSOSOME MEMBRANE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0034327809     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.9.5062     Document Type: Article

References (32)

1. A new member of the immunoglobulin family
2. Characterization of CTLA-4 and CD28 determine the binding to B7-1
3. Complementarity determining region I (CDR1)- and CDR3-analogous regrons in CTLA-4 and CD28 determine the binding to B7-1
4. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BBI in interleukin-2 production and immunotherapy
5. The role of the CD28 receptor during T cell responses to antigen
6. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
7. The B7 and CD28 receptor families
8. CD28-B7 interactions in T-cell activation
9. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
10. CTLA4 can function as a negative regulator of T cell activation
11. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
12. lntracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement
13. + T lymphocytes from Leishmania chagasi-infected mice increase cytokine production and mediate parasite killing after blockade of B7 CTLA-4 molecular pathway
14. CTLA-4 ligation delivers a unique sigmal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction
15. Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevations during a primary systemic in vivo immune response
16. Expression and function of CTLA-4 in TH1 and TH2 cells
17. + T cells
18. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of TH2 responses
19. Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation
20. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-dependent endocytosis that limits cell surface expression
21. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2
22. Interaction of CTLA4 with AP50, a clathrin-coated pit adaptor protein
23. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail
24. Epitopes associated with major histocompatibility cloned T cells. IV. I-J epitopes on MHC-restricted cloned T cells
25. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor
26. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells
27. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes
28. Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail
29. Secretory lysosomes, a special mechanism of regulated secretion in haemopoietic cells
30. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: A possible mechanism for deregulation of T lymphocyte activation
31. Cytolytic T lymphocyte-associated antigen-4 and the TCR ~/CD3 complex, but not CD28, interact with clathfin adaptor complexes AP-1 and AP-2
32. Negative regulation of T cell activation